| Literature DB >> 1350061 |
B Gomez-Mancilla1, J F Latulippe, R Boucher, P J Bédard.
Abstract
Based on the hypothesis that low-threshold calcium conductance in the thalamus might be involved in the pathophysiology of parkinsonian tremor, ethosuximide was given chronically to a monkey previously treated with MPTP and displaying exceptionally a typical rest tremor. After 5 days of daily treatment, the tremor was reduced by 60%. Diltiazem and verapamil which act on different calcium channels had no such effect. Ethosuximide also potentiated the anti-tremor effect of the dopamine D2 agonist LY-171555.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1350061 DOI: 10.1002/mds.870070207
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338